Learn How To Start Xarelto Lawsuit
Our attorneys have filed a mass tort lawsuit on behalf of sufferers who took the blood thinner Xarelto (rivaroxaban) and suffered serious bleeding events. Pharmaceutical companies, like the makers of Xarelto, possess a duty to make sure that their drugs are reasonably protected for use - and failure to perform so might be grounds for compensation. Our lawyers are functioning hard to acquire those hurt by the drug the compensation they're entitled to.
Although bleeding is a common complication linked with anticoagulants, it has been alleged that Xarelto is far more unsafe than conventional blood thinners due to the fact no antidote exists to reverse its blood-thinning effects. This indicates that, inside the event of an emergency, patients might be at threat for irreversible bleeding problems, such as life-threatening internal and gastrointestinal hemorrhaging.
In lasource.org the event you or perhaps a loved one suffered a serious bleeding event soon after taking Xarelto, you may have legal recourse. For a lot more details, get in touch with us nowadays to have your case reviewed, free of charge.
Compensation Possibilities
xarelto-compensation-photoThe plaintiffs in these lawsuits are seeking compensation from Bayer and Janssen for previous and future healthcare bills, lost wages, pain and suffering and, in cases of death, funeral costs. Additionally, they are looking for punitive damages, that are generally awarded to punish the defendant and deter other firms from acting similarly.
Why Are Lawsuits Getting Filed?
Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is harmful and defective. The plaintiffs claim that, unlike classic anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Because of this, the lawsuits claim, doctors have no effective indicates of stopping Xarelto users from bleeding within the event of an emergency. Plaintiffs in the lawsuits allege significant and fatal injuries, like cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.
In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:
The manufacturers of Xarelto marketed the drug as a superior within the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.
The makers of the drug continue to market Xarelto as a safe anticoagulant option.
Doctors and healthcare staff were not properly made aware of methods to stabilize and treat a Xarelto user in the occasion of a bleeding complication.
Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding event.
Xarelto is linked to severe bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing harmful clotting.
Visit this page for much more data on the alleged health risks of Xarelto.
Multidistrict Litigation Trial Dates Set
The attorneys in the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.
